Asarina Pharma AB (publ) (STO:ASAP)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0280
-0.0126 (-31.03%)
Inactive · Last trade price on Oct 1, 2024

Asarina Pharma AB Company Description

Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products.

Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome.

The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016.

Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.

Asarina Pharma AB (publ)
Asarina Pharma AB logo
CountrySweden
Founded2005
IndustryBiotechnology
SectorHealthcare
Employees7
CEOPeter Nordkild

Contact Details

Address:
Karolinska Institutet Science Park
Solna
Phone46 8 52 48 44 82

Stock Details

Ticker SymbolASAP
ExchangeNasdaq Stockholm
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0011641794
SIC Code2834

Key Executives

NamePosition
Peter Nordkild M.D.Chief Executive Officer and Chief Medical Officer
Jakob Dynnes Hansen M.Sc., MBAChief Financial Officer
Torbjörn Bäckström M.D., Ph.D.Chairman of Scientific Advisory Board
Mark DuBoisCommunications Manager
Otto Skolling M.ScChief Business Officer